Joshua H Weinberg1, Ahmad Sweid1, Batoul Hammoud2, Ashlee Asada3, Cannon Greco-Hiranaka4, Keenan Piper4, Michael Reid Gooch1, Stavropoula Tjoumakaris1, Nabeel Herial1, David Hasan5, Hekmat Zarzour1, Robert H Rosenwasser1, Pascal Jabbour6. 1. Department of Neurological Surgery, Thomas Jefferson University Hospital, Philadelphia, PA, USA. 2. Department of Pediatric Endocrinology, Children Hospital of Philadelphia, Philadelphia, PA, USA. 3. Drexel University College of Medicine, Drexel University, Philadelphia, PA, USA. 4. Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA, USA. 5. Department of Neurosurgery, University of Iowa Hospitals and Clinics, Iowa City, IA, USA. 6. Department of Neurological Surgery, Thomas Jefferson University Hospital, Philadelphia, PA, USA. pascal.jabbour@jefferson.edu.
Abstract
PURPOSE: Data in neurointerventional literature is extremely limited regarding the safety and efficacy of flow diversion using transradial access (TRA). We aim to demonstrate the safety and efficacy of intracranial aneurysm treatment with the Pipeline Embolization Device (PED) using TRA compared to transfemoral access (TFA). METHODS: We conducted a retrospective analysis of a prospectively maintained database and identified 79 consecutive patients who underwent neuroendovascular embolization for cerebral aneurysms using the PED from April 2018 through October 2019. Patients were divided into 2 groups: TRA (32 patients) and TFA (47 patients). A comparative analysis was performed between the two groups. RESULTS: There was no significant difference in postoperative intracranial hemorrhage (p>.99), symptomatic ischemic stroke (p=.512), access site complications (p=.268), or other complications (p=.512). However, there was a significant increase in overall complications (14.9% vs. 0.0%, p=.038) and procedure duration (71.4 min ± 31.2 vs. 58.5 ± 20.3, p=.018) in the TFA group. There was no significant difference in complete occlusion at latest follow-up (19/25, 76.0% vs. 35/40, 87.5%; p=.311), 6-month follow-up (17/23, 73.9% vs. 33/38, 86.8%; p=.303), or 12-month follow-up (8/8, 100.0% vs. 5/6, 83.3%; p=.429). There was also no significant difference in rate of retreatment (p>.99), morbidity (p=.512), mortality (p>.99), latest follow-up (p=.985), or loss of follow-up (p=.298). CONCLUSIONS: The feasibility and efficacy of flow diversion with the PED via TRA for the treatment of intracranial aneurysms is comparable to TFA. Widespread adoption of this approach may be facilitated by improvements in device navigation and manipulation via radial-specific engineering.
PURPOSE: Data in neurointerventional literature is extremely limited regarding the safety and efficacy of flow diversion using transradial access (TRA). We aim to demonstrate the safety and efficacy of intracranial aneurysm treatment with the Pipeline Embolization Device (PED) using TRA compared to transfemoral access (TFA). METHODS: We conducted a retrospective analysis of a prospectively maintained database and identified 79 consecutive patients who underwent neuroendovascular embolization for cerebral aneurysms using the PED from April 2018 through October 2019. Patients were divided into 2 groups: TRA (32 patients) and TFA (47 patients). A comparative analysis was performed between the two groups. RESULTS: There was no significant difference in postoperative intracranial hemorrhage (p>.99), symptomatic ischemic stroke (p=.512), access site complications (p=.268), or other complications (p=.512). However, there was a significant increase in overall complications (14.9% vs. 0.0%, p=.038) and procedure duration (71.4 min ± 31.2 vs. 58.5 ± 20.3, p=.018) in the TFA group. There was no significant difference in complete occlusion at latest follow-up (19/25, 76.0% vs. 35/40, 87.5%; p=.311), 6-month follow-up (17/23, 73.9% vs. 33/38, 86.8%; p=.303), or 12-month follow-up (8/8, 100.0% vs. 5/6, 83.3%; p=.429). There was also no significant difference in rate of retreatment (p>.99), morbidity (p=.512), mortality (p>.99), latest follow-up (p=.985), or loss of follow-up (p=.298). CONCLUSIONS: The feasibility and efficacy of flow diversion with the PED via TRA for the treatment of intracranial aneurysms is comparable to TFA. Widespread adoption of this approach may be facilitated by improvements in device navigation and manipulation via radial-specific engineering.
Authors: Brian M Snelling; Samir Sur; Sumedh S Shah; Priyank Khandelwal; Justin Caplan; Rianna Haniff; Robert M Starke; Dileep R Yavagal; Eric C Peterson Journal: J Neurointerv Surg Date: 2018-01-08 Impact factor: 5.836
Authors: Diogo C Haussen; Raul G Nogueira; Keith G DeSousa; Ryan N Pafford; Nazli Janjua; Kevin N Ramdas; Eric C Peterson; Mohamed Samy Elhammady; Dileep R Yavagal Journal: J Neurointerv Surg Date: 2015-01-05 Impact factor: 5.836
Authors: Matthew D Mitchell; Jaekyoung A Hong; Bruce Y Lee; Craig A Umscheid; Sarah M Bartsch; Creighton W Don Journal: Circ Cardiovasc Qual Outcomes Date: 2012-06-26
Authors: Marco Valgimigli; Andrea Gagnor; Paolo Calabró; Enrico Frigoli; Sergio Leonardi; Tiziana Zaro; Paolo Rubartelli; Carlo Briguori; Giuseppe Andò; Alessandra Repetto; Ugo Limbruno; Bernardo Cortese; Paolo Sganzerla; Alessandro Lupi; Mario Galli; Salvatore Colangelo; Salvatore Ierna; Arturo Ausiello; Patrizia Presbitero; Gennaro Sardella; Ferdinando Varbella; Giovanni Esposito; Andrea Santarelli; Simone Tresoldi; Marco Nazzaro; Antonio Zingarelli; Nicoletta de Cesare; Stefano Rigattieri; Paolo Tosi; Cataldo Palmieri; Salvatore Brugaletta; Sunil V Rao; Dik Heg; Martina Rothenbühler; Pascal Vranckx; Peter Jüni Journal: Lancet Date: 2015-03-16 Impact factor: 79.321
Authors: Sanjit S Jolly; Salim Yusuf; John Cairns; Kari Niemelä; Denis Xavier; Petr Widimsky; Andrzej Budaj; Matti Niemelä; Vicent Valentin; Basil S Lewis; Alvaro Avezum; Philippe Gabriel Steg; Sunil V Rao; Peggy Gao; Rizwan Afzal; Campbell D Joyner; Susan Chrolavicius; Shamir R Mehta Journal: Lancet Date: 2011-04-04 Impact factor: 79.321
Authors: Brian M Snelling; Samir Sur; Sumedh Subodh Shah; Megan M Marlow; Mauricio G Cohen; Eric C Peterson Journal: J Neurointerv Surg Date: 2017-09-29 Impact factor: 5.836
Authors: Marlies M Kok; Marieke G M Weernink; Clemens von Birgelen; Anneloes Fens; Liefke C van der Heijden; Janine A van Til Journal: Catheter Cardiovasc Interv Date: 2017-05-04 Impact factor: 2.692
Authors: Muhammad U Manzoor; Ibrahim A Almulhim; Abdullah A Alrashed; Abdulrahman Y Alturki; Fatimah A Alghabban; Sultan M Al-Qahtani Journal: Interv Neuroradiol Date: 2021-09-13 Impact factor: 1.764